Any ideas anyone?

Still think that these shares are really hot... They have had a lot of bad news which has created bad sentiment.... Always good to by on bad sentiment, since the shares have a much higher real value... THESE SHARES ARE REALLY UNDERVALUED

I fear you are telling us what we want to believe....where is your evidence that these shares are hot (and comfirm you mean "good to buy now")...please?
/
Over recent weeks the sp has stabalised about the 50p mark, but that's becasue there is cash to last a little longer and there is every chance they will generate some income, thereby avoiding the need to tap the Market......but "hot"? I fear not - more like "not stone cold".
/
Should the worst happen and they need more cash ( This might be for another line of product/research) -I can see retail investors, like thee and me, being diluted and it is this fear (I presume) along with expectation of delays until 2008 that is holding-back Buying......your investment is fairly safe IMHO, but I don't see this high temperature, please explain.
Many here will have been nursing losses from 2.

I am not a market expert, but PYM turnover jumped up early november. Do you think interest might be increasesd from Hoodia project? as soon as more info comes through....

PYM did a Rights Issue last year so they have some on-going cash - and there was a Unilever deal as well as a vetinary product (could this be the confusion for Animal Rights activity?) - this product is FOR animals to improve their life against itchy skin - which I understand has no alternative cure.....so there.....DYOR as ever.
/
SP fallen today on little News (indeed PYM is reccommended for anyone with a hearing problem).......but it's darn close to a 12 month Low - and that was the lowest it's been for ages.
/
I suppose I have to ask myself Do I feel Lucky - is the Co about to fold? .....Arrgh.
- Still, I hold in hope......maybe being a little silly, eh?
Currently 42p-ish

Hoodia - I've looked at Slim-fash (google) and it is a Unilever "brand" so it's possible this is the brand that will take the hoodia product......but there is no mention of this by Unilever.......and other related sites don't mention hoodia.....so does anyone know for certain where we should look for Unilever info on Release Dates, product prices etc?

brief news article regarding appetite suppressants. from extreme surgical methods to a new product shortly to be available from unilever which induces the sensation of afull stomach. re:lbc 1152 thur 23 am. assume this is hoodia

Share price seems to be falling still...

Excellent article on this site. At least they talked to the company before writing.

Just need an email address to register.

Phytopharm:
Is Phytopharm damaged goods?
(Mar 2006)

In theory Phytopharm has an interesting business plan - develop pharmaceutical drugs based on research into plant extracts from which drug candidates can be purified

http://www.proactiveinvestors.com

some good news today... but will it hold up this time, this share likes to break north very quickerly, the same way it falls... keep an eye on these ones

I had to buy in on these ones... feel the time is right. Results will be out on the Monday 8 May 2006. There will be some sepeculation that the results should be good, possible some profit. This was the recent news release;


Under the terms of the agreement, Phytopharm and Unilever are collaborating on a
five-stage research and development programme of safety and efficacy studies
with a view to bringing new weight management products to market. As part of the
agreement announced in December 2004, Unilever committed to initial payments of
approximately 6.5 million for the first stage and for the second stage have now
committed to a further 3.5 million out of a potential total of 21 million in
payments to Phytopharm. In addition Phytopharm will receive an undisclosed
royalty on sales of all products containing the extract. Unilever is also
managing a separate agronomy programme and supporting the international patent
programme for the products.

Phytopharm licensed the global patent rights for the extract of Hoodia gordonii,
a plant indigenous to South Africa, for incorporation into weight loss products
from the South African Council for Scientific and Industrial Research (CSIR) in
1997.

I would welcome other peoples comments on this company... Shares mag has made a buy recommendation

these shares are booming, I am not a glory hunter but think i was right about there move north, I am going to stock up

up 13% today

Also large x trade went through today, 2,459,817 shares in this one deal... past experiance tells me that whenever a large x trade goes through on a penny share it is a good signal... we will have to wait and see but i feel this one should be in your watchlist... there is a separate thread about large x trades, but can not remember its title, sorry..... comments?

http://www.moneyam.com/TradersRoom/posts.php?tid=9156#lastread

Here you go...

Mega...

These guys are booming, feel they could boom up to 145p... big profit availible.... am I talking to myself... Tonker

Phytopharm PLC has appointed Teather & Greenwood Ltd as joint financial adviser and stockbroker.

Hope you are right TONKER I need 102p to break even, now they have a broker they have a chance.

Feel things are changing for this company, sp is really moving and i feel that there is a lot more to come.... As I said earlier think the results that will be out on the 8 may will be good... lets hope they ramp up! It is a shame other people are not as interested in these type of shares, feel that oil/mining shares dominate these threads... I can only hope people have been reading these posts and have taken action, for i feel that it will be a little late now to make a super profit (but not too late to make a modest 50%)!!!
Regards Tonker
NB. I am a share holder in this company... my opinion will be biased, but I am fundermentally honest...

still going up...

Tonker, I hold also - from about 1 average; here's some hope-bias!
.......The problem with PYM was timing - they were caught up in the Dot-com fiasco and had a huge value - this was always a long-term bet and as far as I see it, they are delivering slowly. The Doggy deal is a regular income and the food-suppliment (if all goes well) should be massive for a small-cap company.
The Results are unlikely to give us anything unexpected, I hoping..... although some further deals would be nice.
PYM always did look super-value but there is no g'tee - whereas Oil-stocks are heading North because Oil is a commodity and that's is unlikely to drop - even $50/b looks cheap "now".
The other problem for PYM was the animal activists - "--so what it's tested on animals? It's a dog medicine, what would you like it tested on, Eh? .."
This also caused the sp to fall, since there was no regular income and folk worried there might be pipeline disruption. The loss of their broker didn't help, but they were not essential to the business, or listing, I understand.
PYM is fully ISA-able and at current prices (say sub-50p) look to turn a decent profit, for the patient.

Thanks hangon, thanks for your comment, am hoping for a quick short term profit with these ones, have already made 45% on these ones and am looking to get out soon.. could resist waiting to hear the results this monday... maybe some more good news as well... as I have mentioned earlier that large x trades in penny shares normally means a good signal for the SP.... now some might say that the new broker will be the good news but there could be more

Quite a bit of Good News has washed-away the market's recent opinions about PYM.
I can understand you wanting to bank a profit (no harm, etc.), but if the pipeline of Royalties is real, then you are throwing away a yield that could be a considerable benefit. Something to consider - for example LLOY is about 7% yield, right now, but anyone taking a punt when the sp was just over 5 will be reaping a yield near 10% (on their investment) - there aren't mny legit places for that return and if there is a TO (for LLOY) a decent cash benefit too.
/
I've been reading stories that BigPharma is starting to worry about their futures - with Patents running out and little to replace them. In the past the "generic" market was a bit jokey and Doctors kept prescribing the old "brands" (since they wern't paying for it). However, now things are different and generics are seen as "good" - that's why I'm holding Bioprogress - that have started to market their "alternative delivery" not just to Big Pharms (=Patent extension), but also directly into the secondary market by offering ingenious packaging/delivery - like PYM they aren't there yet.....but if they succeed then they could become Big Pharma as (BP's) fortunes wane - there is no g'tee that the likes of Glaxo will continue to dominate, say in the next 20 years.
- Buying out PYM and BPRG would seem to me to be a very cheap option for senior Staff at Glaxo, that wish to retire comfortably.
(above is not intended to be a rant, or ramp - I'm not buying these, just holding)

We(holders) are in a position where but for a real accident, these companies are about to move into the early-stages of being BIG ( needs abt. 5-years of growth ). By then they will have regular incomes and the mind-set to continue formulating new products - then by about 20years hence, they may lose their edge, like Big Pharma - and some new development will attempt to topple them.

What's certain IMHO, is my holding in SKP (skypharma) will remain in the jam-tomorrow position they've held for so long. Micap[MIC] may be paired with them, soon, also. However both are in "alternative delivery" and such techniques could (the watch-word) mean that failed drugs suddenly become attractive, FWIW I would support a refinancing of SKP/MIC if they would buy-up recently failed patents, where the fault was in the delivery. New-delivery might (a big guess!) be a way to make fortunes in health esp as the World pop. ages........
Wow!
I must lie down, now.